Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Pustular Psoriasis (GPP)”

62 trials

Showing 20 of 62 results

Large-scale testing (Phase 3)Study completedNCT04061252
What this trial is testing

KHK4827 in Subjects With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Kyowa Kirin Co., Ltd. 126
Large-scale testing (Phase 3)Looking for participantsNCT07219420
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
UCB Biopharma SRL 320
Testing effectiveness (Phase 2)Study completedNCT04572997
What this trial is testing

Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)

Who this might be right for
Palmoplantar Pustulosis
Kristian Reich 21
Testing effectiveness (Phase 2)Study completedNCT03619902
What this trial is testing

Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Vanda Pharmaceuticals 8
Testing effectiveness (Phase 2)Study completedNCT03633396
What this trial is testing

Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Vanda Pharmaceuticals 59
Large-scale testing (Phase 3)Looking for participantsNCT06477536
What this trial is testing

Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Shanghai Huaota Biopharmaceutical Co., Ltd. 33
Testing effectiveness (Phase 2)Ended earlyNCT04493424
What this trial is testing

Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab

Who this might be right for
Palmoplantar Pustulosis
Boehringer Ingelheim 108
Early research (Phase 1)Study completedNCT02978690
What this trial is testing

Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 7
Large-scale testing (Phase 3)Active Not RecruitingNCT06295692
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Janssen Pharmaceutical K.K. 19
Not applicableLooking for participantsNCT07552454
What this trial is testing

Picankibart in Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Xijing Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03988335
What this trial is testing

Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Aristea Therapeutics, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT04057937
What this trial is testing

Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Amgen 90
Large-scale testing (Phase 3)Study completedNCT00353119
What this trial is testing

A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Innovaderm Research Inc. 15
Not applicableStudy completedNCT01780857
What this trial is testing

Immune Signature of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Baylor Research Institute 30
Not applicableWithdrawnNCT06886009
What this trial is testing

Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT03135548
What this trial is testing

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Who this might be right for
Psoriasis
Boehringer Ingelheim 59
Large-scale testing (Phase 3)Study completedNCT02533375
What this trial is testing

Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

Who this might be right for
Generalized Pustular Psoriasis (GPP)AdalimumabJapanese
AbbVie 10
Not applicableLooking for participantsNCT06100991
What this trial is testing

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Who this might be right for
Generalized Pustular Psoriasis
CorEvitas 200
Early research (Phase 1)Study completedNCT05512598
What this trial is testing

HB0034 in Patients With Generalized Pustular Psoriasis (GPP)

Who this might be right for
Generalized Pustular Psoriasis
Shanghai Huaota Biopharmaceutical Co., Ltd. 9
Not applicableActive Not RecruitingNCT06952465
What this trial is testing

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 2,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation